Comparison of Serum Concentrations of Ustekinumab Obtained by Three Commercial Assays in Patients with Crohn's Disease.

Journal: Journal of the Canadian Association of Gastroenterology
Published Date: Mar 31, 2020

Abstract

BACKGROUND: Data on the association of ustekinumab (UST) drug concentrations and clinical outcomes are conflicting. We assessed serum UST drug and anti-UST antibody concentrations using three commercially available assays.

Authors

  • Christine Verdon
    McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • Niels Vande Casteele
    Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • ValĂ©rie Heron
    McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • Pascale Germain
    McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • Waqqas Afif
    McGill University Health Centre, McGill University, Montreal, Quebec, Canada.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals